Home
/
Emmaus Life Sciences, Inc.
/
Financials
/
Quarterly
Emmaus Life Sciences, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Emmaus Life Sciences, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$3.38M
Nov 14, 2025
Q2
2025
Jun 30, 2025
$2.82M
Aug 14, 2025
Q1
2025
Mar 31, 2025
$2.41M
May 15, 2025
Q3
2025
Sep 30, 2024
$5.48M
Nov 14, 2025
Q2
2025
Jun 30, 2024
$5.38M
Aug 14, 2025
Q1
2025
Mar 31, 2024
$2.51M
May 15, 2025
Q3
2024
Sep 30, 2023
$5.02M
Nov 19, 2024
Q2
2024
Jun 30, 2023
$10.76M
Sep 10, 2024
Q1
2024
Mar 31, 2023
$6.75M
Sep 10, 2024
Q3
2023
Sep 30, 2022
$4.94M
Nov 14, 2023
Q2
2023
Jun 30, 2022
$4.29M
Aug 14, 2023
Q1
2023
Mar 31, 2022
$3.23M
May 15, 2023
Q3
2022
Sep 30, 2021
$5.77M
Nov 14, 2022
Q2
2022
Jun 30, 2021
$6.49M
Aug 15, 2022
Q1
2022
Mar 31, 2021
$5.34M
May 13, 2022
Q3
2021
Sep 30, 2020
$5.60M
Nov 12, 2021
Q2
2021
Jun 30, 2020
$4.36M
Sep 1, 2021
Q1
2021
Mar 31, 2020
$6.95M
Sep 1, 2021
Q3
2020
Sep 30, 2019
$5.76M
Aug 26, 2021
Q2
2020
Jun 30, 2019
$5.49M
Aug 26, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.08M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($1.14M)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($1.14M)
Nov 14, 2025
Q1
2025
Mar 31, 2025
($2.33M)
May 15, 2025
Q2
2025
Mar 31, 2025
($2.33M)
Aug 14, 2025
Q3
2025
Mar 31, 2025
($2.33M)
Nov 14, 2025
Q3
2025
Sep 30, 2024
$1.83M
Nov 14, 2025
Q2
2025
Jun 30, 2024
($2.18M)
Aug 14, 2025
Q3
2025
Jun 30, 2024
($2.18M)
Nov 14, 2025
Q2
2025
Mar 31, 2024
($4.35M)
Aug 14, 2025
Q3
2025
Mar 31, 2024
($4.35M)
Nov 14, 2025
Q1
2025
Mar 31, 2024
($4.35M)
May 15, 2025
Q3
2024
Sep 30, 2023
$67.0K
Nov 19, 2024
Q2
2024
Jun 30, 2023
($1.56M)
Sep 10, 2024
Q3
2024
Jun 30, 2023
($1.56M)
Nov 19, 2024
Q1
2024
Mar 31, 2023
($3.45M)
Sep 10, 2024
Q2
2024
Mar 31, 2023
($3.45M)
Sep 10, 2024
Q3
2024
Mar 31, 2023
($3.45M)
Nov 19, 2024
Q3
2023
Sep 30, 2022
($391.0K)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($8.89M)
Aug 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$695.0K
Nov 14, 2025
Q2
2025
Jun 30, 2025
($370.0K)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($980.0K)
May 15, 2025
Q3
2025
Sep 30, 2024
$821.0K
Nov 14, 2025
Q2
2025
Jun 30, 2024
$582.0K
Aug 14, 2025
Q1
2025
Mar 31, 2024
($2.74M)
May 15, 2025
Q3
2024
Sep 30, 2023
$24.0K
Nov 19, 2024
Q2
2024
Jun 30, 2023
$3.33M
Sep 10, 2024
Q1
2024
Mar 31, 2023
($1.17M)
Sep 10, 2024
Q3
2023
Sep 30, 2022
($660.0K)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($1.44M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($3.07M)
May 15, 2023
Q3
2022
Sep 30, 2021
($31.0K)
Nov 14, 2022
Q2
2022
Jun 30, 2021
$483.0K
Aug 15, 2022
Q1
2022
Mar 31, 2021
($1.62M)
May 13, 2022
Q3
2021
Sep 30, 2020
$8.0K
Nov 12, 2021
Q2
2021
Jun 30, 2020
($1.54M)
Sep 1, 2021
Q1
2021
Mar 31, 2020
$1.13M
Sep 1, 2021
Q3
2020
Sep 30, 2019
($4.05M)
Aug 26, 2021
Q3
2019
Jun 30, 2019
($2.70M)
Aug 14, 2019